All News

Serotypes associated with V116 (Merck & Co. Inc.) had higher clinical and economic burden for individuals with invasive pneumococcal disease.

Currently, the drug is being evaluated in a phase 1 clinical trial to determine the safety and efficacy in patients.

A single dose of the vaccine showed long-lasting protection against RSV-associated lower respiratory tract disease in older adults.

Imetelstat (Rytelo; Geron Corp) is a first-in-class telomerase inhibitor.

According to investigators, the primary and key secondary end points were met during the 52-week placebo-controlled period of the trial.

Five medications (tramadol, olanzapine, mirtazapine, bupropion, and atomoxetine) were associated with significantly better OUD remission.

Molly McGraw, PharmD, BCPS, manager of clinical pharmacy at UPMC Health Plan and Kim Castelnovo, RPh, Pharmacy Manager at Community Care Behavioral Health Organization, talk about the importance of mental health care for patients.

With its ability to decode genetic variations influencing drug response, pharmacogenomics holds immense promise in reshaping health care delivery.

Pharmacy technicians can expand their skills to explores career growth.

Expert discusses the challenges faced by pharmacists in palliative and hospice care.

Guidance for pharmacy technicians as they continue to learn and start their careers.

By improving health insurance coverage and cost of inhalers, such as out-of-pocket caps, access to care can be increased. Some companies are aiming to improve access by implementing price caps.

Mirikizumab met both co-primary end points and all secondary end points at week 52, according to results presented at Digestive Disease Week in Washington DC.

Over the course of 15 years, epigenetic and transcriptional analysis of postmortem brain samples have revealed underlying molecular differences.

FKS518 (Fresenius Kabi) would be indicated for the treatment of osteoporosis in men and women, including glucocorticoid-induced osteoporosis and bone loss due to prostate or breast cancer.

Expert discusses the challenges faced by pharmacists in palliative and hospice care.

Tune into this special episode of “Public Health Matters” to hear Emma White, the founder and president of the nonprofit organization Life Is Worth It, discuss her mental health journey and how she used it to educate adolescents, teenagers, and young adults on mental wellness.

Emily Griffin discusses her career in pharmacy and in digital content creation.

The investigators are optimistic that the data can establish stress-related pathways while revealing potential therapeutic options for patients with major depressive disorder and post-traumatic stress disorder.

Nicolas Girard, MD, PhD, discusses the results of the PALOMA-2 trial, highlighting the subcutaneous (SC) delivery of amivantamab combined with lazertinib as a first-line treatment for advanced non-small cell lung cancer (NSCLC) with EGFR mutations.

Data show women with poor cardiovascular health may have an increased risk of early signs of cognitive decline in midlife.

For patients with a blood eosinophil count of 150 cells/µL or greater, tezepelumab had a significant reduction of approximately 37% in the rate of moderate or severe exacerbations.

Lisocabtagene maraleucel is being investigated for mantle cell lymphoma, relapsed or refractory (R/R) large B-cell lymphoma, and R/R follicular lymphoma.

Approximately 40% of caregivers make dosing errors when administering liquid medication to children.

Body mass index is the main driver of type 2 diabetes globally, accounting for 52.2% of disability-adjusted life years.

Pharmacists play a crucial role in managing pain for cancer patients in palliative care.

The panelists expressed concerns about clinical trial data and concluded that the benefits do not outweigh the risks, but the FDA does not have to follow their recommendation.

In addition to racial inequities in access to care, socioeconomic challenges are very common for the specialty medications necessary in MS.